The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells

Blood

Volumn 114, Issue 20, 2009, Pages 4432-4440

  Taillardet, Morgan ^a,b   Haffar, Ghina ^a,b   Mondière, Paul ^a,b   Asensio, Marie Jeanne ^a,b   Gheit, Hanane ^a,b   Burdin, Nicolas ^c   Defrance, Thierry ^a,b   Genestier, Laurent ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CPG1668 OLIGODEOXYNUCLEOTIDE; PNEUMOCOCCUS POLYSACCHARIDE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG; BACTERIAL POLYSACCHARIDE; BACTERIAL PROTEIN; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; PNEUMOCOCCUS VACCINE; THYMUS INDEPENDENT ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CONTROLLED STUDY; IMMUNIZATION; MOUSE; NONHUMAN; PLASMA CELL; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; THYMUS; ANIMAL; BACTERIAL MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, T-INDEPENDENT; BACTERIAL CAPSULES; BACTERIAL PROTEINS; BONE MARROW CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGIC MEMORY; MICE; OLIGODEOXYRIBONUCLEOTIDES; PLASMA CELLS; PNEUMOCOCCAL VACCINES; POLYSACCHARIDES, BACTERIAL; STREPTOCOCCUS PNEUMONIAE; THYMUS GLAND;

EID: 73349125084     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-01-200014     Document Type: Article

References (38)

1. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol. 1995;13:655-692.
2. Harding CV, Roof RW, Allen PM, Unanue ER. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc Natl Acad Sci U S A. 1991;88(7):2740-2744.
3. Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14(5):617-629.
4. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005;23(1):7-18.
5. Alugupalli KR, Leong JM, Woodland RT, Muramatsu M, Honjo T, Gerstein RM. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity. 2004;21(3):379-390.
6. Hosokawa T. Studies on B-cell memory, II: T-cell independent antigen can induce B-cell memory. Immunology. 1979;38(2):291-299.
7. Brodeur PH, Wortis HH. Regulation of thymus-independent responses: unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies. J Immunol. 1980;125(4):1499-1505.
8. Schuler W, Schuler A, Kolsch E. Immune response against the T-independent antigen alpha (1-3) dextran, II: occurrence of B gamma memory cells in the course of immunization with the native polysaccharide is T cell dependent. Eur J Immunol. 1984;14(6):578-585.
9. Zhang J, Liu YJ, MacLennan IC, Gray D, Lane PJ. B cell memory to thymus-independent antigens type 1 and type 2: the role of lipopolysaccharide in B memory induction. Eur J Immunol. 1988;18(9):1417-1424.
10. Obukhanych TV, Nussenzweig MC. T-independent type II immune responses generate memory B cells. J Exp Med. 2006;203(2):305-310.
11. Manz RA, Thiel A, Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 1997;388(6638):133-134.
12. Slifka MK, Antia R, Whitmire JK, Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 1998;8(3):363-372.
13. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol. 2005;23:367-386.
14. Genestier L, Taillardet M, Mondiere P, Gheit H, Bella C, Defrance T. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J Immunol. 2007;178(12):7779-7786.
15. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944-950.
16. Choi YS, Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med. 2008;205(13):3053-3064.
17. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med. 1991;325(21):1453-1460.
18. Bolan G, Broome CV, Facklam RR, Plikaytis BD, Fraser DW, Schlech WF III. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med. 1986;104(1):1-6.
19. Chu RS, McCool T, Greenspan NS, Schreiber JR, Harding CV. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharideprotein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun. 2000;68(3):1450-1456.
20. Sen G, Chen Q, Snapper CM. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels. Infect Immun. 2006;74(4):2177-2186.
21. Kovarik J, Bozzotti P, Tougne C, et al. Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens. Immunology. 2001;102(1):67-76.
22. Balázs M, Martin F, Zhou T, Kearney J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity. 2002;17(3):341-352.
23. Lesinski GB, Westerink MA. Novel vaccine strategies to T-independent antigens. J Microbiol Methods. 2001;47(2):135-149.
24. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298(5601):2199-2202.
25. Makinodan T, Kastenbaum MA, Peterson WJ. Radiosensitivity of spleen cells from normal and preimmunized mice and its significance to intact animals. J Immunol. 1962;88:31-37.
26. Okudaira H, Ishizaka K. Reaginic antibody formation in the mouse, XI: participation of long-lived antibody-forming cells in persistent antibody formation. Cell Immunol. 1981;58(1):188-201.
27. Holt PG, Sedgwick JD, O'Leary C, Krska K, Leivers S. Long-lived IgE- and IgG-secreting cells in rodents manifesting persistent antibody responses. Cell Immunol. 1984;89(2):281-289.
28. Vieira P, Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988;18(2):313-316.
29. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357(19):1903-1915.
30. Garg M, Subbarao B. Immune responses of systemic and mucosal lymphoid organs to PnuImune vaccine as a function of age and the efficacy of monophosphoryl lipid A as an adjuvant. Infect Immun. 1992;60(6):2329-2336.
31. Lee KG, Xu S, Wong ET, Tergaonkar V, Lam KP. Bruton's tyrosine kinase separately regulates NF{kappa}B p65RelA activation and cytokine interleukin (IL)-10/IL-12 production in TLR9-stimulated B cells. J Biol Chem. 2008;283(17):11189-11198.
32. Pasare C, Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature. 2005;438(7066):364-368.
33. Meyer-Bahlburg A, Khim S, Rawlings DJ. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J Exp Med. 2007;204(13):3095-3101.
34. Koch G, Benner R. Differential requirement for B-memory and T-memory cells in adoptive antibody formation in mouse bone marrow. Immunology. 1982;45(4):697-704.
35. Muehlinghaus G, Cigliano L, Huehn S, et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood. 2005;105(10):3965-3971.
36. Fairfax KA, Corcoran LM, Pridans C, et al. Different kinetics of blimp-1 induction in B cell subsets revealed by reporter gene. J Immunol. 2007;178(7):4104-4111.
37. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, Calame K. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med. 2005;202(11):1471-1476.
38. Ferraro AJ, Drayson MT, Savage CO, MacLennan IC. Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. Eur J Immunol. 2008;38(1):292-298.